ArticleBMC biology2025
stGRL: spatial domain identification, denoising, and imputation algorithm for spatial transcriptome data based on multi-task graph contrastive representation learning.
Article in BMC biology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
9 citing papers in PubMed.
- SPIDER: spatially integrated denoising via embedding regularization with single cell supervision.Bioinformatics (Oxford, England) · 2026Article
- CAGNet: a structure-aware clustering-alternated graph network for cell-cell interaction inference in spatial transcriptomics.BMC bioinformatics · 2026Article
- Review
- Compact and informative representation learning for scRNA-seq data clustering with masked information bottleneck.BMC biology · 2026Article
- Poly pipeline: a polyvalent spatial transcriptomics workflow validated across polyploid and diploid organisms.GigaByte (Hong Kong, China) · 2026Article
- Research progress on the role of MZB1 in immune regulation.Frontiers in immunology · 2026Review
- Perspective on the integration of radiomics and spatial omics in the analysis of the tumor microenvironment of bladder cancer and prospects for precision diagnosis and treatment.Frontiers in immunology · 2026Review
- SLGCA: spatial cross-level graph contrastive autoencoder for multislice spatial domain identification and microenvironment exploration.Briefings in bioinformatics · 2025Article
- Integrating Spatial Omics and Deep Learning: Toward Predictive Models of Cardiomyocyte Differentiation Efficiency.Bioengineering (Basel, Switzerland) · 2025Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
7 authors.
Funding
Abstract
backgroundSpatial transcriptomics now enables sequencing while preserving the spatial location of cells. This significantly enhances researchers' understanding of cellular and tissue functions in their spatial context. However, due to current technical limitations, spatial transcriptomics data often exhibit high dropout rates and noise, posing challenges for downstream analysis, like spot clustering, differential gene analysis, and spatial domain identification. To address those challenges, we propose stGRL, a novel deep multi-task graph neural network model tailored for spatial transcriptomics. stGRL employs an encoder-decoder architecture with a zero-inflated negative binomial (ZINB) distribution to reconstruct input data while effectively addressing dropout events. Additionally, it integrates graph contrastive representation learning to enhance the consistency of node embeddings, thereby improving clustering performance.
resultsThrough benchmark experiments on various spatial transcriptomics datasets, stGRL demonstrated a superior ability to identify spatial features compared to current mainstream methods. In-depth analyses reveal that the denoised data generated by stGRL not only preserves the spatial hierarchy of tissues but also accurately identifies differentially expressed genes. When applied to breast cancer datasets, stGRL effectively analyzed the differences between cancerous regions and carcinoma in situ areas, uncovering that carcinoma in situ regions are predominantly regulated by the immune system, which limits cancer cell development through inflammatory responses. Additionally, in the spatial transcriptomics analysis of ovarian cancer, stGRL successfully annotated cell types, accurately identified B cell-enriched regions, and discovered a novel target gene, MZB1, with potential therapeutic value.
conclusionsstGRL is an effective method for integrating multiple tasks in spatial transcriptome analysis. Our study highlights its broad applicability and outstanding performance in analyzing spatial transcriptome data. This method offers a powerful analytical tool for uncovering the spatial heterogeneity of complex tissues and identifying potential therapeutic targets for disease.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.